Cell penetrating peptide conjugates of steric block oligonucleotides

被引:143
作者
Lebleu, Bernard [3 ]
Moulton, Hong M. [2 ]
Abes, Rachida [3 ]
Ivanova, Gabriela D. [1 ]
Abes, Said [3 ]
Stein, David A. [2 ]
Iversen, Patrick L. [2 ]
Arzumanov, Andrey A. [1 ]
Gait, Michael J. [1 ]
机构
[1] Mol Biol Lab, Med Res Council, Cambridge CB2 2QH, England
[2] AVI BioPharma Inc, Corvallis, OR 97333 USA
[3] Univ Montpellier 2, UMR CNRS 5235, F-34095 Montpellier, France
基金
英国医学研究理事会;
关键词
CPP; PNA; PMO; splicing modulation; nuclear delivery; bioavailability;
D O I
10.1016/j.addr.2007.09.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Charge neutral steric block oligonucleotide analogues, such as peptide nucleic acids (PNA) or phosphorodiamidate morpholino oligomers (PMO), have promising biological and pharmacological properties for antisense applications, such as for example in mRNA splicing redirection. However, cellular uptake of free oligomers is poor and the utility of conjugates of PNA or PMO to cell penetrating peptides (CPP), such as Tat or Penetratin, is limited by endosomal sequestration. Two new families of arginine-rich CPPs named (R-Ahx-R)(4) AhxB and R(6)Pen allow efficient nuclear delivery of splice correcting PNA and PMO at micromolar concentrations in the absence of endosomolytic agents. The in vivo efficacy of (R-Ahx-R)(4) AhxB PMO conjugates has been demonstrated in mouse models of Duchenne muscular dystrophy and in various viral infections. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:517 / 529
页数:13
相关论文
共 100 条
[1]   Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides [J].
Abes, S. ;
Moulton, H. ;
Turner, J. ;
Clair, P. ;
Richard, J. P. ;
Iversen, P. ;
Gait, M. J. ;
Lebleu, B. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :53-55
[2]   Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates [J].
Abes, S ;
Williams, D ;
Prevot, P ;
Thierry, A ;
Gait, MJ ;
Lebleu, B .
JOURNAL OF CONTROLLED RELEASE, 2006, 110 (03) :595-604
[3]   Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide [J].
Abes, Said ;
Turner, John J. ;
Ivanova, Gabriela D. ;
Owen, David ;
Williams, Donna ;
Arzumanov, Andrey ;
Clair, Philippe ;
Gait, Michael J. ;
Lebleu, Bernard .
NUCLEIC ACIDS RESEARCH, 2007, 35 (13) :4495-4502
[4]   Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents [J].
Abes, Said ;
Moulton, Hong M. ;
Clair, Philippe ;
Prevot, Paul ;
Youngblood, Derek S. ;
Wu, Rebecca P. ;
Iversen, Patrick L. ;
Lebleu, Bernard .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (03) :304-313
[5]   Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid [J].
Albertshofer, K ;
Siwkowski, AM ;
Wancewicz, EV ;
Esau, CC ;
Watanabe, T ;
Nishihara, KC ;
Kinberger, GA ;
Malik, L ;
Eldrup, AB ;
Manoharan, M ;
Geary, RS ;
Monia, BP ;
Swayze, EE ;
Griffey, RH ;
Bennett, CF ;
Maier, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) :6741-6749
[6]   DOWN-REGULATION OF AMYLOID PRECURSOR PROTEIN INHIBITS NEURITE OUTGROWTH IN-VITRO [J].
ALLINQUANT, B ;
HANTRAYE, P ;
MAILLEUX, P ;
MOYA, K ;
BOUILLOT, C ;
PROCHIANTZ, A .
JOURNAL OF CELL BIOLOGY, 1995, 128 (05) :919-927
[7]   Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology [J].
Alter, J ;
Lou, F ;
Rabinowitz, A ;
Yin, HF ;
Rosenfeld, J ;
Wilton, SD ;
Partridge, TA ;
Lu, QL .
NATURE MEDICINE, 2006, 12 (02) :175-177
[8]   Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate [J].
Amantana, Adams ;
Moulton, Hong M. ;
Cate, Melissa L. ;
Reddy, Muralimohan T. ;
Whitehead, Tom ;
Hassinger, Jed N. ;
Youngblood, Derek S. ;
Iversen, Patrick L. .
BIOCONJUGATE CHEMISTRY, 2007, 18 (04) :1325-1331
[9]   SYNTHESIS AND ANTIVIRAL ACTIVITY OF PEPTIDE-OLIGONUCLEOTIDE CONJUGATES PREPARED BY USING N-ALPHA-(BROMOACETYL)PEPTIDES [J].
ARAR, K ;
AUBERTIN, AM ;
ROCHE, AC ;
MONSIGNY, M ;
MAYER, R .
BIOCONJUGATE CHEMISTRY, 1995, 6 (05) :573-577
[10]   A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2′-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), α-L-LNA, or 2′-thio-LNA residues [J].
Arzumanov, A ;
Stetsenko, DA ;
Malakhov, AD ;
Reichelt, S ;
Sorensen, MD ;
Babu, BR ;
Wengel, J ;
Gait, MJ .
OLIGONUCLEOTIDES, 2003, 13 (06) :435-453